| Business Type | Manufacturer, Exporter, Supplier, Retailer, Trader, Distributor, Importer |
| Range of Products | Anti Cancer |
| Medicine Type | Allopathic |
| Dosage Type | Oral |
| Click to view more | |
Product Details
infigratinib) 125mg is a prescription targeted kinase inhibitor used to treat adults with previously treated, advanced bile duct cancer (cholangiocarcinoma) containing an FGFR2 gene fusion or rearrangement. The recommended dose is 125mg taken orally once daily for 21 days, followed by 7 days off, in 28-day
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.